CORRECTION article

Front. Pharmacol., 31 March 2025

Sec. Neuropharmacology

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1592653

Corrigendum: Riluzole attenuates acute neural injury and reactive gliosis, hippocampal-dependent cognitive impairments and spontaneous recurrent generalized seizures in a rat model of temporal lobe epilepsy

  • 1. Neuroscience Center of Excellence, School of Medicine, Louisiana State University Health-New Orleans, New Orleans, LA, United States

  • 2. Department of Pharmacology, School of Medicine, University of California-Davis, Davis, CA, United States

Article metrics

View details

1k

Views

316

Downloads

In the published article, the legend of Supplementary Figure S1 was mistakenly not included in the publication. The missing legend appears below:

SUPPLEMENTARY FIGURE S1 Riluzole attenuates neural degeneration in the mediodorsal thalamus caused by KA-induced SE. Riluzole-treated rats showed less FJC labeling (green) than the KA group in the mediodorsal thalamus at 7 days (top row) and 14 days (bottom row). *Indicates the 3rd ventricle. Low power (200x) and high power (400x) was captured using an exposure time of 400 ms. Scale bar = 200 μM for low power and 50 μM for high power.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

acute neural injury, kainic acid, neuroprotection, neuroinflammatory response, microglia and astrocytes, epileptogenesis, antiepileptogenic drug

Citation

Kyllo T, Allocco D, Vande Hei L, Wulff H and Erickson JD (2025) Corrigendum: Riluzole attenuates acute neural injury and reactive gliosis, hippocampal-dependent cognitive impairments and spontaneous recurrent generalized seizures in a rat model of temporal lobe epilepsy. Front. Pharmacol. 16:1592653. doi: 10.3389/fphar.2025.1592653

Received

12 March 2025

Accepted

18 March 2025

Published

31 March 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

16 - 2025

Updates

Copyright

*Correspondence: Jeffrey D. Erickson,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics